Optimal management of RA patients who require Biologic Therapy (ORBIT) – a randomised controlled, non-inferiority study

<h4>Background</h4> <p>Tumour necrosis factor inhibition (TNFi) and B cell depletion are highly effective treatments for active rheumatoid arthritis (RA) but to date no randomised controlled trials have directly compared their safety, efficacy and cost effectiveness. This study was...

Full description

Bibliographic Details
Main Authors:	Porter, D, van Melckebeke, J, Dale, J, Messow, C, McConnachie, P, Walker, A, Munro, R, McLaren, J, McRorie, E, Packham, J, Buckley, C, Harvie, J, Pitzalis, C, Taylor, P, Choy, E, McInnes, I
Format:	Journal article
Published:	Elsevier 2016

Optimal management of RA patients who require Biologic Therapy (ORBIT) – a randomised controlled, non-inferiority study

Similar Items